Literature DB >> 24953427

The endocannabinoid system modulates stress, emotionality, and inflammation.

Molly S Crowe1, Sara R Nass1, Kristin M Gabella1, Steven G Kinsey2.   

Abstract

The physiological and behavioral effects of stress are well characterized. Endocannabinoids are produced on demand and function to attenuate many of the physiological effects of the stress response. The endocannabinoid system is made up of cannabinoid receptors, the fatty acid signaling molecules that bind to and activate these receptors, and the enzymes that synthesize and catabolize these endocannabinoid signaling molecules. Cannabinoid research has recently grown substantially, due in no small part to the development of genetic research models as well as highly selective pharmaceutical tools. The purpose of this minireview is to discuss a subset of the many parallels between cannabinoid and behavioral neuroimmunology research, with specific discussion of interactions between the endocannabinoid system and psychological stress, emotionality, and inflammation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Cannabinoid; Corticosterone; Depression; Inflammation; Neuroimmune pharmacology; Stress

Mesh:

Substances:

Year:  2014        PMID: 24953427     DOI: 10.1016/j.bbi.2014.06.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  23 in total

1.  Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.

Authors:  Laura Kranaster; Carolin Hoyer; Suna Su Aksay; Jan Malte Bumb; F Markus Leweke; Christoph Janke; Manfred Thiel; Beat Lutz; Laura Bindila; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-24       Impact factor: 5.270

2.  MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice.

Authors:  Molly S Crowe; Steven G Kinsey
Journal:  Eur J Pharmacol       Date:  2017-05-03       Impact factor: 4.432

3.  Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2.

Authors:  Sabrina Francesca Lisboa; Anzela Niraula; Leonardo Barbosa Resstel; Francisco Silveira Guimaraes; Jonathan P Godbout; John F Sheridan
Journal:  Neuropsychopharmacology       Date:  2018-04-17       Impact factor: 7.853

Review 4.  Emerging drugs for the treatment of anxiety.

Authors:  James W Murrough; Sahab Yaqubi; Sehrish Sayed; Dennis S Charney
Journal:  Expert Opin Emerg Drugs       Date:  2015-06-01       Impact factor: 4.191

5.  The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.

Authors:  Michelle Sexton; Jose M Garcia; Aminah Jatoi; Carey S Clark; Mark S Wallace
Journal:  J Natl Cancer Inst Monogr       Date:  2021-11-28

Review 6.  Endogenous opioids: opposing stress with a cost.

Authors:  Rita J Valentino; Elisabeth Van Bockstaele
Journal:  F1000Prime Rep       Date:  2015-05-12

7.  Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.

Authors:  Chaela Presley; Ammaar Abidi; Satyendra Suryawanshi; Suni Mustafa; Bernd Meibohm; Bob M Moore
Journal:  Pharmacol Res Perspect       Date:  2015-07-06

8.  Endogenous Opioids: The Downside of Opposing Stress.

Authors:  Rita J Valentino; Elisabeth Van Bockstaele
Journal:  Neurobiol Stress       Date:  2015-01-01

9.  Uremic Pruritus Is Not Associated with Endocannabinoid Receptor 1 Gene Polymorphisms.

Authors:  Monika Heisig; Łukasz Łaczmański; Adam Reich; Felicja Lwow; Jacek C Szepietowski
Journal:  Biomed Res Int       Date:  2016-02-29       Impact factor: 3.411

10.  Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.

Authors:  Luca Carnevali; Federica Vacondio; Stefano Rossi; Emilio Macchi; Gilberto Spadoni; Annalida Bedini; Inga D Neumann; Silvia Rivara; Marco Mor; Andrea Sgoifo
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.